Dual-mixed HIV-1 coreceptor tropism and HIV-associated neurocognitive deficits

[1]  I. Grant,et al.  Human Immunodeficiency Virus Infection Heightens Concurrent Risk of Functional Dependence in Persons With Long-Term Methamphetamine Use , 2013, Journal of addiction medicine.

[2]  H. Skinner,et al.  The drug abuse screening test. , 2013, Addictive behaviors.

[3]  I. Grant,et al.  Substance use is a risk factor for neurocognitive deficits and neuropsychiatric distress in acute and early HIV infection , 2013, Journal of NeuroVirology.

[4]  David R. Holtgrave,et al.  Increased levels of CD4 T-cell activation in individuals with CXCR4 using viruses in primary HIV-1 infection , 2012, AIDS.

[5]  G. Annoni,et al.  Neurocognitive Impairment in HIV-Infected Naïve Patients with Advanced Disease: The Role of Virus and Intrathecal Immune Activation , 2012, Clinical & developmental immunology.

[6]  L. Vandekerckhove,et al.  Presence of CXCR4-using HIV-1 in patients with recently diagnosed infection: correlates and evidence for transmission. , 2012, The Journal of infectious diseases.

[7]  Thomas Lengauer,et al.  Geno2pheno[454]: A Web Server for the Prediction of HIV-1 Coreceptor Usage from Next-Generation Sequencing Data , 2012, Intervirology.

[8]  K. Metzner,et al.  Characterization of human immunodeficiency virus type 1 (HIV-1) diversity and tropism in 145 patients with primary HIV-1 infection. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[9]  Thomas Lengauer,et al.  Prediction of HIV-1 coreceptor usage (tropism) by sequence analysis using a genotypic approach. , 2011, Journal of visualized experiments : JoVE.

[10]  S. Letendre.  Central nervous system complications in HIV disease: HIV-associated neurocognitive disorder. , 2011, Topics in antiviral medicine.

[11]  Ying Wu,et al.  Abnormalities in Resting-State Functional Connectivity in Early Human Immunodeficiency Virus Infection , 2011, Brain Connect..

[12]  Michael J. Taylor,et al.  Demographically corrected norms for African Americans and Caucasians on the Hopkins Verbal Learning Test–Revised, Brief Visuospatial Memory Test–Revised, Stroop Color and Word Test, and Wisconsin Card Sorting Test 64-Card Version , 2011, Journal of clinical and experimental neuropsychology.

[13]  Eric S. Rosenberg,et al.  Alterations in brain metabolism during the first year of HIV infection , 2011, Journal of NeuroVirology.

[14]  Z. Su,et al.  Reanalysis of coreceptor tropism in HIV-1-infected adults using a phenotypic assay with enhanced sensitivity. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[15]  Jianhui Zhong,et al.  Persistence of HIV-associated cognitive impairment, inflammation, and neuronal injury in era of highly active antiretroviral treatment , 2011, AIDS.

[16]  Michael J. Taylor,et al.  Normative data and validation of a regression based summary score for assessing meaningful neuropsychological change , 2011, Journal of clinical and experimental neuropsychology.

[17]  E. Daar.  Faculty Opinions recommendation of HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. , 2011 .

[18]  B. Ances,et al.  Pathogenesis of HIV in the Central Nervous System , 2010, Current HIV/AIDS reports.

[19]  C. Fennema-Notestine,et al.  Neurocognitive functioning in acute or early HIV infection , 2010, Journal of NeuroVirology.

[20]  D. Richman,et al.  Evaluation of an HIV Nucleic Acid Testing Program With Automated Internet and Voicemail Systems to Deliver Results , 2010, Annals of Internal Medicine.

[21]  B. Ances,et al.  Neurologic complications of HIV disease and their treatment. , 2010, Topics in HIV medicine : a publication of the International AIDS Society, USA.

[22]  C. Rouzioux,et al.  High frequency of X4/DM-tropic viruses in PBMC samples from patients with primary HIV-1 subtype-B infection in 1996-2007: the French ANRS CO06 PRIMO Cohort Study. , 2009, The Journal of antimicrobial chemotherapy.

[23]  E. Rosenberg,et al.  Changes in MRS neuronal markers and T cell phenotypes observed during early HIV infection , 2009, Neurology.

[24]  M. Churchill,et al.  Tissue-Specific Sequence Alterations in the Human Immunodeficiency Virus Type 1 Envelope Favoring CCR5 Usage Contribute to Persistence of Dual-Tropic Virus in the Brain , 2009, Journal of Virology.

[25]  Paolo Piazza,et al.  Emergence and persistence of CXCR4-tropic HIV-1 in a population of men from the multicenter AIDS cohort study. , 2008, The Journal of infectious diseases.

[26]  Steven Wolinsky,et al.  Bioinformatic prediction programs underestimate the frequency of CXCR4 usage by R5X4 HIV type 1 in brain and other tissues. , 2008, AIDS research and human retroviruses.

[27]  D. Richman,et al.  Persistence of Transmitted Drug Resistance among Subjects with Primary Human Immunodeficiency Virus Infection , 2008, Journal of Virology.

[28]  J. Becker,et al.  Updated research nosology for HIV-associated neurocognitive disorders , 2007, Neurology.

[29]  C. Petropoulos,et al.  Baseline HIV type 1 coreceptor tropism predicts disease progression. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[30]  N. Volkow,et al.  Structural and metabolic brain changes in the striatum associated with methamphetamine abuse. , 2007, Addiction.

[31]  L. Ruiz,et al.  Prevalence of X4 tropic viruses in patients recently infected with HIV-1 and lack of association with transmission of drug resistance. , 2007, The Journal of antimicrobial chemotherapy.

[32]  Lei Wang,et al.  A multicenter observational study of the potential benefits of initiating combination antiretroviral therapy during acute HIV infection. , 2006, The Journal of infectious diseases.

[33]  I. Grant,et al.  Construct validity of Hopkins Verbal Learning Test-Revised component process measures in an HIV-1 sample. , 2005, Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists.

[34]  C. Petropoulos,et al.  HIV-1 chemokine coreceptor utilization in paired cerebrospinal fluid and plasma samples: a survey of subjects with viremia. , 2005, The Journal of infectious diseases.

[35]  K. Marder,et al.  Evaluation of HIV RNA and markers of immune activation as predictors of HIV-associated dementia , 2004, Neurology.

[36]  T. B. Üstün,et al.  The World Mental Health (WMH) Survey Initiative version of the World Health Organization (WHO) Composite International Diagnostic Interview (CIDI) , 2004, International journal of methods in psychiatric research.

[37]  Robert K. Heaton,et al.  Predictive Validity of Global Deficit Scores in Detecting Neuropsychological Impairment in HIV Infection , 2004, Journal of clinical and experimental neuropsychology.

[38]  Carla J. Reicks,et al.  The impact of HIV-associated neuropsychological impairment on everyday functioning , 2004, Journal of the International Neuropsychological Society.

[39]  I. Grant,et al.  Methamphetamine dependence increases risk of neuropsychological impairment in HIV infected persons , 2004, Journal of the International Neuropsychological Society.

[40]  B. Korber,et al.  Genetic and Functional Analysis of Full-Length Human Immunodeficiency Virus Type 1 env Genes Derived from Brain and Blood of Patients with AIDS , 2003, Journal of Virology.

[41]  Michael P Busch,et al.  Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection , 2003, AIDS.

[42]  Ralph H. B. Benedict,et al.  Hopkins Verbal Learning Test—Revised: Normative data and analysis of inter-form and test–retest reliability. , 1998 .

[43]  R. Connor,et al.  Change in Coreceptor Use Correlates with Disease Progression in HIV-1–Infected Individuals , 1997, The Journal of experimental medicine.

[44]  D. Richman,et al.  The impact of the syncytium-inducing phenotype of human immunodeficiency virus on disease progression. , 1994, The Journal of infectious diseases.

[45]  D. Ho,et al.  Genotypic and phenotypic characterization of HIV-1 patients with primary infection. , 1993, Science.

[46]  M. Bukrinsky,et al.  Chemokine receptors on brain endothelia--keys to HIV-1 neuroinvasion? , 2001, Advances in experimental medicine and biology.

[47]  J. Farber,et al.  Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. , 1999, Annual review of immunology.

[48]  D. Kolson,et al.  Chemokine receptors in the human brain and their relationship to HIV infection. , 1998, Journal of neurovirology.

[49]  R. Reitan,et al.  The Halstead-Reitan neuropsychological test battery: Theory and clinical interpretation , 1993 .

[50]  M. Schlossberg.  The Halstead-Reitan Neuropsychological Test Battery: Theory and Clinical Interpretation. , 1986 .

[51]  L. Bérubé,et al.  [Clinical neuropsychology]. , 1982, Nursing Quebec.